Public perceptions of predictive testing for rheumatoid arthritis compared to breast cancer and early-onset Alzheimer's disease: a qualitative study

被引:6
|
作者
Singhal, Juhi [1 ]
Wells, Imogen [2 ]
Simons, Gwenda [2 ]
Wohlke, Sabine [3 ]
Raza, Karim [2 ,3 ,4 ,5 ]
Falahee, Marie [2 ]
机构
[1] Univ Birmingham, Coll Med & Dent Sci, Birmingham, W Midlands, England
[2] Univ Birmingham, Queen Elizabeth Hosp, Coll Med & Dent Sci,Res Labs, Inst Inflammat & Ageing,Rheumatol Res Grp, Birmingham B15 2WB, W Midlands, England
[3] Hamburg Univ Appl Sci, Fac Life Sci, Dept Hlth Sci, Hamburg, Germany
[4] MRC Versus Arthrit Ctr Musculoskeletal Ageing Res, Birmingham, W Midlands, England
[5] Univ Birmingham, Coll Med & Dent Sci, Res Inflammatory Arthrit Ctr Versus Arthrit, Birmingham B15 2TT, W Midlands, England
关键词
Predictive testing; Risk perception; Rheumatoid arthritis; Breast cancer; Early-onset Alzheimer's disease; Focus groups; ECONOMIC BURDEN; RISK; DIAGNOSIS; DELAY;
D O I
10.1186/s41927-021-00244-w
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background There is increasing research focus on prediction and prevention of rheumatoid arthritis (RA). Information about risk of RA is increasingly available via direct-to-consumer testing. However, there is limited understanding of public perceptions around predictive testing for RA. This study explores public perceptions of predictive testing for RA in comparison to breast cancer (BC) and early-onset Alzheimer's disease (AD). Methods Four focus groups with 21 members of the public were conducted using hypothetical vignettes about predictive testing for each disease. Transcripts of focus group proceedings were analysed inductively using thematic analysis. Results Thematic analysis of the data produced three key themes: decision-making factors, consequences, and consumer needs. Factors suggested that might influence decision-making about predictive testing included family history, fear, and perceived severity and treatability of the illness. RA was perceived to be less severe and more treatable than BC/AD. Potential consequences of predictive testing across all diseases included lifestyle modification, planning for the future and discrimination by employers or insurers. Predictive testing for RA was perceived to have less potential for negative psychological consequences than other diseases. Participants highlighted that individuals undertaking predictive testing should be signposted to appropriate support services and receive information on the accuracy of predictive testing. It was suggested that strategies to mitigate concerns regarding communication and confidentiality of risk results are required. Conclusions The findings of this study reflect public misunderstandings regarding RA that may impact the uptake of and responses to predictive testing, and key informational needs of individuals considering a predictive test. Predictive strategies should be accompanied by awareness-raising initiatives and informational resources.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Exercise and Early-Onset Alzheimer's Disease: Theoretical Considerations
    Hooghiemstra, Astrid M.
    Eggermont, Laura H. P.
    Scheltens, Philip
    van der Flier, Wiesje M.
    Scherder, Erik J. A.
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA, 2012, 2 (01): : 132 - 145
  • [32] Dissecting the clinical heterogeneity of early-onset Alzheimer's disease
    Sirkis, Daniel W.
    Bonham, Luke W.
    Johnson, Taylor P.
    La Joie, Renaud
    Yokoyama, Jennifer S.
    MOLECULAR PSYCHIATRY, 2022, 27 (06) : 2674 - 2688
  • [33] The genetic landscape of early-onset Alzheimer's disease in China
    Qin, Wei
    Li, Fang-Yu
    Liu, Wen-Ying
    Li, Ying
    Cao, Shu-Man
    Wei, Yi-Ping
    Li, Yan
    Wang, Qi
    Wang, Qi-Geng
    Jia, Jian-Ping
    ALZHEIMERS & DEMENTIA, 2025, 21 (02)
  • [34] Molecular genetics of early-onset Alzheimer's disease revisited
    Cacace, Rita
    Sleegers, Kristel
    Van Broeckhoven, Christine
    ALZHEIMERS & DEMENTIA, 2016, 12 (06) : 733 - 748
  • [35] Case of early-onset Alzheimer's disease with atypical manifestation
    Lin Zhu
    Limin Sun
    Lin Sun
    Shifu Xiao
    上海精神医学, 2021, (01) : 56 - 59
  • [36] Early-Onset Alzheimer’s Disease: What Is Missing in Research?
    Temitope Ayodele
    Ekaterina Rogaeva
    Jiji T. Kurup
    Gary Beecham
    Christiane Reitz
    Current Neurology and Neuroscience Reports, 2021, 21
  • [37] Early-Onset Alzheimer's Disease: What Is Missing in Research?
    Ayodele, Temitope
    Rogaeva, Ekaterina
    Kurup, Jiji T.
    Beecham, Gary
    Reitz, Christiane
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2021, 21 (02)
  • [38] TYROBP genetic variants in early-onset Alzheimer's disease
    Pottier, Cyril
    Ravenscroft, Thomas A.
    Brown, Patricia H.
    Finch, NiCole A.
    Baker, Matt
    Parsons, Meeia
    Asmann, Yan W.
    Ren, Yingxue
    Christopher, Elizabeth
    Levitch, Denise
    van Blitterswijk, Marka
    Cruchaga, Carlos
    Campion, Dominique
    Nicolas, Gael
    Richard, Anne-Claire
    Guerreiro, Rita
    Bras, Jose T.
    Zuchner, Stephan
    Gonzalez, Michael A.
    Bu, Guojun
    Younkin, Steven
    Knopman, David S.
    Josephs, Keith A.
    Parisi, Joseph E.
    Petersen, Ronald C.
    Ertekin-Taner, Nilufer
    Graff-Radford, Neill R.
    Boeve, Bradley F.
    Dickson, Dennis W.
    Rademakers, Rosa
    NEUROBIOLOGY OF AGING, 2016, 48 : 222.e9 - 222.e15
  • [39] Dissecting the clinical heterogeneity of early-onset Alzheimer’s disease
    Daniel W. Sirkis
    Luke W. Bonham
    Taylor P. Johnson
    Renaud La Joie
    Jennifer S. Yokoyama
    Molecular Psychiatry, 2022, 27 : 2674 - 2688
  • [40] Pregnancy Exacerbates Early-Onset Familial Alzheimer's Disease
    Croese, Tommaso
    Ramos, Javier Maria Peralta
    Castellani, Giulia
    Ferrera, Shir
    Falik-Zaccai, Tzipora
    Aharon-Peretz, Judith
    Schwartz, Michal
    NEUROLOGY, 2021, 96 (15)